(Q35528860)

8 August 2017

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. (English)

1 reference

high-grade prostatic intraepithelial neoplasia

8 August 2017

phase III clinical trial

0 references

0 references

1 reference

7

Scott M Lippman

1 reference

8 August 2017

9

David S Alberts

1 reference

8 August 2017

James R Marshall

1

1 reference

8 August 2017

Catherine M Tangen

2

1 reference

8 August 2017

Wael A Sakr

3

1 reference

8 August 2017

David P Wood

4

1 reference

8 August 2017

Donna L Berry

5

1 reference

8 August 2017

Eric A Klein

6

1 reference

8 August 2017

Howard L Parnes

8

1 reference

8 August 2017

David F Jarrard

10

1 reference

8 August 2017

W Robert Lee

11

1 reference

8 August 2017

J Michael Gaziano

12

1 reference

8 August 2017

E David Crawford

13

1 reference

8 August 2017

Benjamin Ely

14

1 reference

8 August 2017

Michael Ray

15

1 reference

8 August 2017

Warren Davis

16

1 reference

8 August 2017

Lori M Minasian

17

1 reference

8 August 2017

Ian M Thompson

18

1 reference

8 August 2017

6 September 2011

1 reference

Cancer Prevention Research

8 August 2017

1 reference

8 August 2017

4

1 reference

8 August 2017

1761-1769

1 reference

8 August 2017

11

1 reference

Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Effect of dutasteride on the risk of prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Rethinking screening for breast cancer and prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Finasteride decreases the risk of prostatic intraepithelial neoplasia.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Active surveillance for prostate cancer: for whom?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

High-grade prostatic intraepithelial neoplasia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

The influence of finasteride on the development of prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Chemoprevention of prostate cancer: current status and future directions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Prostatic intraepithelial neoplasia is a risk factor for cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Surrogate end points in cancer research: a critique.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Premalignant lesions of the prostate.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Serum levels of selenium and retinol and the subsequent risk of cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Effective treatment for early-stage prostate cancer--possible, necessary, or both?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Prostatic intraepithelial neoplasia: the preinvasive stage of prostate cancer. Overview of the prostate committee report

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Serum selenium and subsequent risk of prostate cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

A case-control study of toenail selenium and cancer of the breast, colon, and prostate

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208719

Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III)

15 November 2018

1 reference

12 December 2020

Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens

1 reference

12 December 2020

Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling?

1 reference

12 December 2020

Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development

1 reference

12 December 2020

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

1 reference

12 December 2020

Prediagnostic serum selenium and risk of cancer

1 reference

12 December 2020

Precursors of prostatic cancer: progression, regression and chemoprevention

1 reference

12 December 2020

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

1 reference

12 December 2020

Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial

1 reference

12 December 2020

Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia

1 reference

12 December 2020

Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma

1 reference

12 December 2020

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer

1 reference

12 December 2020

10.1158/1940-6207.CAPR-10-0343

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference